GNPX
Genprex, Inc.
There isn't enough reported data to score GNPX yet.
GNPX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
GNPX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
GNPX PE Valuation
GNPX has no meaningful PE right now: it lost money over the past year.
GNPX Forward outlook
There aren't enough analyst estimates for GNPX to show an outlook.
GNPX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$222.88 | +$2,792.22 |
| Q1 2026 | -$400.48 | +$5,727.62 |
| Q4 2025 | -$672.40 | +$9,228.70 |
| Q3 2025 | -$1,772.10 | +$11,076.50 |
| Q2 2025 | -$3,015.10 | +$14,200.50 |
| Q1 2025 | -$6,128.10 | +$14,387.50 |
| Q4 2024 | -$9,901.10 | +$14,915.50 |
| Q3 2024 | -$12,848.60 | +$13,817.34 |
GNPX is still losing money, but far less than before: $222.88 per share over the past year, against $33,880.00 at its worst in late 2019.
GNPX Quarterly Revenue
GNPX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.1M | -$1.3M |
| Q1 2026 | -$3.1M | +$1M |
| Q4 2025 | -$4.1M | -$228.8K |
| Q3 2025 | -$3.2M | -$1M |
| Q2 2025 | -$3.9M | +$1.9M |
| Q1 2025 | -$4.2M | +$1.1M |
| Q4 2024 | -$3.9M | +$1.1M |
| Q3 2024 | -$2.2M | +$2.5M |
GNPX has burned cash in almost every quarter: −$16M over the past year, against −$14M the year before.
GNPX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +50% | +157K shares |
| 1 year | +1786% | +448K shares |
| 3 years | +41996% | +472K shares |
| 5 years | +45616% | +472K shares |
| Available history | +131334% | +473K shares |
GNPX has 473,162 diluted shares, up 1786% from a year ago.
GNPX Net Leverage
GNPX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GNPX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 10.6 | Oversold |
GNPX's weekly RSI is 30 (oversold) and its Stochastic is 11 (oversold).
GNPX PE vs Healthcare Sector
GNPX has no meaningful PE right now: it lost money over the past year.
GNPX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.39 | 7.5% below |
| 20 week MA | $4.60 | 52% below |
| 50 week MA | $23.8 | 91% below |
| 100 week MA | $193.0 | 99% below |
| 200 week MA | $8,789.4 | 100% below |
GNPX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
GNPX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12,001.0 | $206,360.0 | +1620% |
| 2021 | $206,360.0 | $63,360.0 | -69% |
| 2022 | $63,360.0 | $44,000.0 | -31% |
| 2023 | $44,000.0 | $10,120.0 | -77% |
| 2024 | $10,120.0 | $962.9 | -90% |
| 2025 | $962.9 | $39.4 | -96% |
| 2026 YTD | $39.4 | $2.21 | -94% |
GNPX has finished five years in a row lower, and it's down 94% so far in 2026.